<DOC>
	<DOCNO>NCT00849030</DOCNO>
	<brief_summary>The aim study test whether Arimidex alone combination Tamoxifen beneficial treatment breast cancer .</brief_summary>
	<brief_title>ATAC - Arimidex , Tamoxifen Alone Combination</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Patients histologically proven operable invasive breast cancer Patients complete primary surgery chemotherapy ( give ) , candidate receive hormonal adjuvant therapy Women define postmenopausal Patients clinical evidence metastatic disease Patients , whatever reason ( e.g . confusion , infirmity , alcoholism ) , unlikely comply trial requirement Patients whose chemotherapy start 8 week ( ie 56 day ) completion primary surgery whose chemotherapy complete 8 week ( ie 56 day ) start randomise treatment</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>